Multiple receptor tyrosine kinase activation attenuates therapeutic efficacy of the fibroblast growth factor receptor 2 inhibitor AZD4547 in <i>FGFR2</i> amplified gastric cancer

Jinjia Chang(Fudan University Shanghai Cancer Center), Jin Li(Fudan University)
Oncotarget
December 10, 2014
Cited by 49


Related Papers